Label‑free quantitative proteomics and bioinformatics analyses of alcoholic liver disease in a chronic and binge mouse model

Zhang,Yu; Zhan,Cheng; Chen,Genwen; Sun,Jianyong

doi:10.3892/mmr.2018.9225

Label‑free quantitative proteomics and bioinformatics analyses of alcoholic liver disease in a chronic and binge mouse model

Authors:
- Yu Zhang
- Cheng Zhan
- Genwen Chen
- Jianyong Sun
View Affiliations

Affiliations: Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China, Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China
Published online on: June 26, 2018 https://doi.org/10.3892/mmr.2018.9225
Pages: 2079-2087
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As a significant cause of mortality and morbidity, alcoholic liver disease (ALD) has been widely investigated. However, little is known about the underlying metabolic mechanisms involved in the complicated pathological processes of ALD. The present study used label‑free quantitative proteomics and bioinformatics analyses to investigate the differentially expressed proteins (DEPs) and their functions in the livers of alcohol‑feed (AF) and control pair‑feed (PF) mice. As a result, 87 upregulated DEPs and 133 downregulated DEPs were identified in AF liver tissues compared with PF livers. Gene ontology and Kyoto encyclopedia of genes and genomes bioinformatics analyses demonstrated that the DEPs were significantly enriched in ‘protein binding’, ‘metabolism’, ‘signal conduction’ and ‘immune response’. The expression of several core proteins including thyroid hormone receptor interactor 12 (TRIP12), NADH dehydrogenase (ubiquinone)1 α subcomplex, assembly factor 3 (NDUFAF3) and guanine monophosphate synthetase (GMPS) was validated by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) in a larger series of samples. The RT‑qPCR results confirmed that TRIP12, NDUFAF3 and GMPS genes were significantly differentially expressed in between the AF and PF samples. These results extend our understanding of the molecular mechanisms underlying the occurrence and development of ALD. The present study indicated that the majority of DEPs serve vital roles in multiple metabolic pathways and this extends our knowledge of the molecular mechanisms involved in the occurrence and progression of ALD.

View Figures

View References

1	Rehm J, Samokhvalov AV and Shield KD: Global burden of alcoholic liver diseases. J Hepatol. 59:160–168. 2013. View Article : Google Scholar : PubMed/NCBI
2	Allampati S and Mullen KD: Long-term management of alcoholic liver disease. Clin Liver Dis. 20:551–562. 2016. View Article : Google Scholar : PubMed/NCBI
3	Dugum M and McCullough A: Diagnosis and management of alcoholic liver disease. J Clin Transl Hepatol. 3:109–116. 2015. View Article : Google Scholar : PubMed/NCBI
4	Hoek JB, Cahill A and Pastorino JG: Alcohol and mitochondria: A dysfunctional relationship. Gastroenterology. 122:2049–2063. 2002. View Article : Google Scholar : PubMed/NCBI
5	Ceni E, Mello T and Galli A: Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J Gastroenterol. 20:17756–17772. 2014. View Article : Google Scholar : PubMed/NCBI
6	Szabo G: Gut-liver axis in alcoholic liver disease. Gastroenterology. 148:30–36. 2015. View Article : Google Scholar : PubMed/NCBI
7	Titz B, Elamin A, Martin F, Schneider T, Dijon S, Ivanov NV, Hoeng J and Peitsch MC: Proteomics for systems toxicology. Comput Struct Biotechnol J. 11:73–90. 2014. View Article : Google Scholar : PubMed/NCBI
8	Tzeng SC and Maier CS: Label-free proteomics assisted by affinity enrichment for elucidating the chemical reactivity of the liver mitochondrial proteome toward adduction by the lipid electrophile 4-hydroxy-2-nonenal (HNE). Front Chem. 4:22016. View Article : Google Scholar : PubMed/NCBI
9	Bantscheff M, Lemeer S, Savitski MM and Kuster B: Quantitative mass spectrometry in proteomics: Critical review update from 2007 to the present. Anal Bioanal Chem. 404:939–965. 2012. View Article : Google Scholar : PubMed/NCBI
10	Nan YM, Kong LB, Ren WG, Wang RQ, Du JH, Li WC, Zhao SX, Zhang YG, Wu WJ, Di HL, et al: Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice. Lipids Health Dis. 12:112013. View Article : Google Scholar : PubMed/NCBI
11	Bailey SM, Andringa KK, Landar A and Darley-Usmar VM: Proteomic approaches to identify and characterize alterations to the mitochondrial proteome in alcoholic liver disease. Methods Mol Biol. 447:369–380. 2008. View Article : Google Scholar : PubMed/NCBI
12	Zhan C, Yan L, Wang L, Jiang W, Zhang Y, Xi J, Jin Y, Chen L, Shi Y, Lin Z and Wang Q: Landscape of expression profiles in esophageal carcinoma by the cancer genome atlas data. Dis Esophagus. 29:920–928. 2016. View Article : Google Scholar : PubMed/NCBI
13	Yan L, Zhan C, Wu J and Wang S: Expression profile analysis of head and neck squamous cell carcinomas using data from the cancer genome atlas. Mol Med Rep. 13:4259–4265. 2016. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Gene Ontology Consortium, . The Gene Ontology (GO) project in 2006. Nucleic Acids Res. 34:D322–D326. 2006. View Article : Google Scholar : PubMed/NCBI
16	Kanehisa M, Goto S, Kawashima S, Okuno Y and Hattori M: The KEGG resource for deciphering the genome. Nucleic Acids Res. 32:D277–D280. 2004. View Article : Google Scholar : PubMed/NCBI
17	Kim DH, Lee EM, Do SH, Jeong DH and Jeong KS: Changes of the cytoplasmic proteome in response to alcoholic hepatotoxicity in rats. Int J Mol Sci. 16:18664–18682. 2015. View Article : Google Scholar : PubMed/NCBI
18	Lee SJ, Lee DE, Kang JH, Nam MJ, Park JW, Kang BS, Lee DS, Lee HS and Kwon OS: New potential biomarker proteins for alcoholic liver disease identified by a comparative proteomics approach. J Cell Biochem. 118:1189–11200. 2017. View Article : Google Scholar : PubMed/NCBI
19	Tran M, Yang Z, Liangpunsakul S and Wang L: Metabolomics analysis revealed distinct cyclic changes of metabolites altered by chronic ethanol-plus-binge andshp deficiency. Alcohol Clin Exp Res. 40:2548–2556. 2016. View Article : Google Scholar : PubMed/NCBI
20	Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R and Gao B: Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3. Hepatology. 52:1291–1300. 2010. View Article : Google Scholar : PubMed/NCBI
21	Bertola A, Mathews S, Ki SH, Wang H and Gao B: Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 8:627–637. 2013. View Article : Google Scholar : PubMed/NCBI
22	Choi G and Runyon BA: Alcoholic hepatitis: A clinician's guide. Clin Liver Dis. 16:371–385. 2012. View Article : Google Scholar : PubMed/NCBI
23	Mathurin P and Lucey MR: Management of alcoholic hepatitis. Drug Ther Bull. 56:S39–S45. 2012.
24	Patel VJ, Thalassinos K, Slade SE, Connolly JB, Crombie A, Murrell JC and Scrivens JH: A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J Proteome Res. 8:3752–3759. 2009. View Article : Google Scholar : PubMed/NCBI
25	Bantscheff M, Lemeer S, Savitski MM and Kuster B: Quantitative mass spectrometry in proteomics: Critical review update from 2007 to the present. Anal Bioanal Chem. 404:939–965. 2012. View Article : Google Scholar : PubMed/NCBI
26	Sprecher H: New advances in fatty-acid biosynthesis. Nutrition. 12 1 Suppl:S5–S7. 1996. View Article : Google Scholar : PubMed/NCBI
27	Pace CP and Stankovich MT: Oxidation-reduction properties of short-chain acyl-CoA dehydrogenase: Effects of substrate analogs. Arch Biochem Biophys. 313:261–266. 1994. View Article : Google Scholar : PubMed/NCBI
28	Ladero JM, Martinez C, Garcia-Martin E, Fernández-Arquero M, López-Alonso G, de la Concha EG, Díaz-Rubio M and Agúndez JA: Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease. Scand J Gastroenterol. 40:348–353. 2005. View Article : Google Scholar : PubMed/NCBI
29	Eaton S, Record CO and Bartlett K: Multiple biochemical effects in the pathogenesis of alcoholic fatty liver. Eur J Clin Invest. 27:719–722. 1997. View Article : Google Scholar : PubMed/NCBI
30	Cunningham CC and Bailey SM: Ethanol consumption and liver mitochondria function. Biol Signals Recept. 10:271–282. 2001. View Article : Google Scholar : PubMed/NCBI
31	Chacko BK, Srivastava A, Johnson MS, Benavides GA, Chang MJ, Ye Y, Jhala N, Murphy MP, Kalyanaraman B and Darley-Usmar VM: Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology. 54:153–163. 2011. View Article : Google Scholar : PubMed/NCBI
32	Sugimoto K and Takei Y: Pathogenesis of alcoholic liver disease. Hepatol Res. 47:70–79. 2016. View Article : Google Scholar : PubMed/NCBI
33	Williams JA, Ni H, Ding Y and Ding W: Parkin regulates mitophagy and mitochondrial function to protect against alcohol-induced liver injury and steatosis in mice. Am J Physiol Gastrointest Liver Physiol. 309:G324–G340. 2015. View Article : Google Scholar : PubMed/NCBI
34	Lieber CS and DeCarli LM: Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding. Science. 162:917–918. 1968. View Article : Google Scholar : PubMed/NCBI
35	Lieber CS and DeCarli LM: Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. J Biol Chem. 245:2505–2512. 1970.PubMed/NCBI
36	Robin M, Sauvage I, Grandperret T, Descatoire V, Pessayre D and Fromenty B: Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. Febs Lett. 579:6895–6902. 2005. View Article : Google Scholar : PubMed/NCBI
37	Cieślak A, Kelly I, Trottier J, Verreault M, Wunsch E, Milkiewicz P, Poirier G, Droit A and Barbier O: Selective and sensitive quantification of the cytochrome P450 3A4 protein in human liver homogenates through multiple reaction monitoring mass spectrometry. Proteomics. 16:2827–2837. 2016. View Article : Google Scholar : PubMed/NCBI
38	Bradford BU, Kono H, Isayama F, Kosyk O, Wheeler MD, Akiyama TE, Bleye L, Krausz KW, Gonzalez FJ, Koop DR and Rusyn I: Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology. 41:336–344. 2005. View Article : Google Scholar : PubMed/NCBI
39	Lieber CS: The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev. 36:511–529. 2004. View Article : Google Scholar : PubMed/NCBI
40	Nieto N: Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology. 35:62–73. 2002. View Article : Google Scholar : PubMed/NCBI
41	Bridle K, Cheung TK, Murphy T, Walters M, Anderson G, Crawford DG and Fletcher LM: Hepcidin is down-regulated in alcoholic liver injury: Implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res. 30:106–112. 2006. View Article : Google Scholar : PubMed/NCBI
42	Suzuki Y, Saito H, Suzuki M, Hosoki Y, Sakurai S, Fujimoto Y and Kohgo Y: Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res. 26:26S–31S. 2002. View Article : Google Scholar : PubMed/NCBI
43	Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y and Kato J: Dysregulation of systemic iron metabolism in alcoholic liver diseases. J Gastroenterol Hepatol. 23 Suppl 1:S78–S81. 2008. View Article : Google Scholar : PubMed/NCBI
44	Bai T, Yang Y, Yao YL, Sun P, Lian LH, Wu YL and Nan JX: Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway. Pharmacol Res. 105:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
45	Angiuoli SV, Matalka M, Gussman A, Galens K, Vangala M, Riley DR, Arze C, White JR, White O and Fricke WF: CloVR: A virtual machine for automated and portable sequence analysis from the desktop using cloud computing. BMC Bioinformatics. 12:3562011. View Article : Google Scholar : PubMed/NCBI